Anshul Thakral

Anshul Thakral has a diverse and extensive work experience. Anshul currently serves as a Board Member at Opthea and Orsini Specialty Pharmacy. In 2022, they held roles as the Chief Executive Officer (CEO) at Launch Therapeutics, as well as a Board Member at Saama and a Venture Partner at Abingworth. Anshul also worked as an Operating Executive at The Carlyle Group. In 2021, they became a Board Member at TriNetX. Prior to these roles, they held various positions at PPD, including Chief Commercial Officer (CCO) and EVP, Peri- and Post-Approval Services. Anshul was also involved with the Newark Mentoring Movement as a Co-founder and member of the Board of Directors. Additionally, they served as the General Manager, Lifesciences at GLG (Gerson Lehrman Group).

Anshul Thakral has a Master of Business Administration (MBA) degree in Finance and Marketing from The Wharton School, which was completed from 2004 to 2006. Prior to that, from 1998 to 2000, they obtained a Master's degree in Biomedical/Medical Engineering from The Johns Hopkins University. Anshul also holds a Bachelor of Science (BS) degree in Biomedical Engineering from The Johns Hopkins University, where they studied from 1995 to 2000. Anshul completed their high school education at Arcadia High School, although specific years were not provided.